Q03135
- CAV1_HUMAN
UniProt
Q03135 - CAV1_HUMAN
(max 400 entries)x
Your basket is currently empty.
Select item(s) and click on "Add to basket" to create your own collection here
(400 entries max)
Protein
Caveolin-1
Gene
CAV1
Organism
Homo sapiens (Human)
Status
Functioni
May act as a scaffolding protein within caveolar membranes. Interacts directly with G-protein alpha subunits and can functionally regulate their activity (By similarity). Involved in the costimulatory signal essential for T-cell receptor (TCR)-mediated T-cell activation. Its binding to DPP4 induces T-cell proliferation and NF-kappa-B activation in a T-cell receptor/CD3-dependent manner. Recruits CTNNB1 to caveolar membranes and may regulate CTNNB1-mediated signaling through the Wnt pathway.By similarity2 Publications
GO - Molecular functioni
- cholesterol binding Source: HGNC
- enzyme binding Source: UniProtKB
- nitric-oxide synthase binding Source: BHF-UCL
- patched binding Source: BHF-UCL
- peptidase activator activity Source: BHF-UCL
- protein complex scaffold Source: BHF-UCL
- receptor binding Source: BHF-UCL
- structural molecule activity Source: UniProtKB
GO - Biological processi
- angiogenesis Source: Ensembl
- apoptotic signaling pathway Source: UniProtKB
- blood coagulation Source: Reactome
- calcium ion homeostasis Source: BHF-UCL
- calcium ion transport Source: BHF-UCL
- caveola assembly Source: BHF-UCL
- caveolin-mediated endocytosis Source: UniProtKB
- cellular calcium ion homeostasis Source: BHF-UCL
- cellular response to hyperoxia Source: UniProtKB
- cellular response to starvation Source: BHF-UCL
- cholesterol homeostasis Source: BHF-UCL
- cholesterol transport Source: HGNC
- cytosolic calcium ion homeostasis Source: BHF-UCL
- inactivation of MAPK activity Source: BHF-UCL
- lactation Source: Ensembl
- leukocyte migration Source: Reactome
- lipid storage Source: BHF-UCL
- maintenance of protein location in cell Source: BHF-UCL
- mammary gland development Source: BHF-UCL
- mammary gland involution Source: BHF-UCL
- MAPK cascade Source: Ensembl
- membrane depolarization Source: BHF-UCL
- negative regulation of anoikis Source: UniProtKB
- negative regulation of BMP signaling pathway Source: BHF-UCL
- negative regulation of canonical Wnt signaling pathway Source: UniProtKB
- negative regulation of cytokine-mediated signaling pathway Source: Ensembl
- negative regulation of endothelial cell proliferation Source: BHF-UCL
- negative regulation of epithelial cell differentiation Source: BHF-UCL
- negative regulation of JAK-STAT cascade Source: BHF-UCL
- negative regulation of MAPK cascade Source: BHF-UCL
- negative regulation of nitric oxide biosynthetic process Source: BHF-UCL
- negative regulation of nitric-oxide synthase activity Source: Ensembl
- negative regulation of peptidyl-serine phosphorylation Source: BHF-UCL
- negative regulation of pinocytosis Source: UniProt
- negative regulation of protein binding Source: BHF-UCL
- negative regulation of protein ubiquitination Source: UniProtKB
- negative regulation of transcription from RNA polymerase II promoter Source: UniProtKB
- negative regulation of tyrosine phosphorylation of Stat5 protein Source: Ensembl
- nitric oxide homeostasis Source: BHF-UCL
- nitric oxide metabolic process Source: Reactome
- positive regulation of calcium ion transport into cytosol Source: BHF-UCL
- positive regulation of canonical Wnt signaling pathway Source: BHF-UCL
- positive regulation of extrinsic apoptotic signaling pathway Source: UniProtKB
- positive regulation of intrinsic apoptotic signaling pathway Source: UniProtKB
- positive regulation of metalloenzyme activity Source: BHF-UCL
- positive regulation of peptidyl-serine phosphorylation Source: BHF-UCL
- positive regulation of vasoconstriction Source: BHF-UCL
- protein homooligomerization Source: BHF-UCL
- protein localization Source: BHF-UCL
- receptor internalization involved in canonical Wnt signaling pathway Source: BHF-UCL
- regulation of blood coagulation Source: BHF-UCL
- regulation of fatty acid metabolic process Source: BHF-UCL
- regulation of nitric-oxide synthase activity Source: Reactome
- regulation of peptidase activity Source: BHF-UCL
- regulation of smooth muscle contraction Source: BHF-UCL
- regulation of the force of heart contraction by chemical signal Source: Ensembl
- response to calcium ion Source: BHF-UCL
- response to estrogen Source: MGI
- response to hypoxia Source: BHF-UCL
- response to ischemia Source: Ensembl
- response to progesterone Source: MGI
- skeletal muscle tissue development Source: BHF-UCL
- small molecule metabolic process Source: Reactome
- T cell costimulation Source: UniProtKB
- triglyceride metabolic process Source: BHF-UCL
- vasculogenesis Source: BHF-UCL
- vasoconstriction Source: Ensembl
- vesicle organization Source: BHF-UCL
- viral process Source: UniProtKB-KW
Keywords - Biological processi
Host-virus interactionEnzyme and pathway databases
Reactomei | REACT_12477. eNOS activation. REACT_12541. NOSTRIN mediated eNOS trafficking. REACT_12560. Basigin interactions. REACT_494. Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis. |
SignaLinki | Q03135. |
Protein family/group databases
TCDBi | 8.A.26.1.1. the caveolin (caveolin) family. |
Names & Taxonomyi
Protein namesi | Recommended name: Caveolin-1 |
Gene namesi | Name:CAV1 Synonyms:CAV |
Organismi | Homo sapiens (Human) |
Taxonomic identifieri | 9606 [NCBI] |
Taxonomic lineagei | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo |
Proteomesi | UP000005640: Chromosome 7 |
Organism-specific databases
HGNCi | HGNC:1527. CAV1. |
Subcellular locationi
Golgi apparatus membrane; Peripheral membrane protein. Cell membrane; Peripheral membrane protein. Membrane › caveola; Peripheral membrane protein. Membrane raft
Note: Colocalized with DPP4 in membrane rafts. Potential hairpin-like structure in the membrane. Membrane protein of caveolae.
Note: Colocalized with DPP4 in membrane rafts. Potential hairpin-like structure in the membrane. Membrane protein of caveolae.
GO - Cellular componenti
- acrosomal membrane Source: Ensembl
- apical plasma membrane Source: BHF-UCL
- basolateral plasma membrane Source: BHF-UCL
- caveola Source: UniProtKB
- cell cortex Source: Ensembl
- cilium Source: Ensembl
- cytoplasmic vesicle Source: UniProtKB
- endocytic vesicle membrane Source: Reactome
- endoplasmic reticulum Source: HGNC
- endosome Source: UniProtKB
- focal adhesion Source: UniProtKB
- Golgi membrane Source: HGNC
- integral component of plasma membrane Source: Ensembl
- intracellular Source: BHF-UCL
- lipid particle Source: Reactome
- membrane raft Source: UniProtKB
- perinuclear region of cytoplasm Source: UniProtKB
- plasma membrane Source: UniProtKB
- protein complex Source: MGI
Keywords - Cellular componenti
Cell membrane, Golgi apparatus, MembranePathology & Biotechi
Involvement in diseasei
Congenital generalized lipodystrophy 3 (CGL3) [MIM:612526]: An autosomal recessive disorder characterized by a near complete absence of adipose tissue, extreme insulin resistance, hypertriglyceridemia, hepatic steatosis and early onset of diabetes.1 Publication
Note: The disease is caused by mutations affecting the gene represented in this entry.
Note: The disease is caused by mutations affecting the gene represented in this entry.
Pulmonary hypertension, primary, 3 (PPH3) [MIM:615343]: A rare disorder characterized by plexiform lesions of proliferating endothelial cells in pulmonary arterioles. The lesions lead to elevated pulmonary arterial pression, right ventricular failure, and death. The disease can occur from infancy throughout life and it has a mean age at onset of 36 years. Penetrance is reduced. Although familial pulmonary hypertension is rare, cases secondary to known etiologies are more common and include those associated with the appetite-suppressant drugs.1 Publication
Note: The disease is caused by mutations affecting the gene represented in this entry.
Note: The disease is caused by mutations affecting the gene represented in this entry.
Partial lipodystrophy, congenital cataracts, and neurodegeneration syndrome (LCCNS) [MIM:606721]: A form of familial partial lipodystrophy associated with congenital cataracts and neurodegeneration leading to cerebellar and spinal cord dysfunction.1 Publication
Note: The disease is caused by mutations affecting the gene represented in this entry.
Note: The disease is caused by mutations affecting the gene represented in this entry.
Keywords - Diseasei
Congenital generalized lipodystrophy, Disease mutationOrganism-specific databases
MIMi | 606721. phenotype. 612526. phenotype. 615343. phenotype. |
Orphaneti | 528. Berardinelli-Seip congenital lipodystrophy. 220393. Diffuse cutaneous systemic sclerosis. 275777. Heritable pulmonary arterial hypertension. 220402. Limited cutaneous systemic sclerosis. |
PharmGKBi | PA26107. |
PTM / Processingi
Molecule processing
Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | Actions |
---|---|---|---|---|---|---|
Initiator methioninei | 1 – 1 | 1 | Removed3 Publications | |||
Chaini | 2 – 178 | 177 | Caveolin-1 | PRO_0000004764 | Add BLAST |
Amino acid modifications
Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | Actions |
---|---|---|---|---|---|---|
Modified residuei | 2 – 2 | 1 | N-acetylserine3 Publications | |||
Modified residuei | 5 – 5 | 1 | N6-acetyllysine1 Publication | |||
Modified residuei | 6 – 6 | 1 | Phosphotyrosine1 Publication | |||
Modified residuei | 14 – 14 | 1 | Phosphotyrosine; by ABL12 Publications | |||
Modified residuei | 25 – 25 | 1 | Phosphotyrosine1 Publication | |||
Modified residuei | 37 – 37 | 1 | Phosphoserine5 Publications | |||
Modified residuei | 42 – 42 | 1 | Phosphotyrosine | |||
Lipidationi | 133 – 133 | 1 | S-palmitoyl cysteineBy similarity | |||
Lipidationi | 143 – 143 | 1 | S-palmitoyl cysteineBy similarity | |||
Lipidationi | 156 – 156 | 1 | S-palmitoyl cysteineBy similarity |
Post-translational modificationi
The initiator methionine for isoform 2 is removed during or just after translation. The new N-terminal amino acid is then N-acetylated.3 Publications
Phosphorylated at Tyr-14 by ABL1 in response to oxidative stress.7 Publications
Keywords - PTMi
Acetylation, Lipoprotein, Palmitate, PhosphoproteinProteomic databases
MaxQBi | Q03135. |
PaxDbi | Q03135. |
PeptideAtlasi | Q03135. |
PRIDEi | Q03135. |
PTM databases
PhosphoSitei | Q03135. |
Expressioni
Tissue specificityi
Expressed in muscle and lung, less so in liver, brain and kidney.
Gene expression databases
Bgeei | Q03135. |
CleanExi | HS_CAV1. |
ExpressionAtlasi | Q03135. baseline and differential. |
Genevestigatori | Q03135. |
Organism-specific databases
HPAi | CAB003791. |
Interactioni
Subunit structurei
Homooligomer. Interacts with GLIPR2, NOSTRIN, SNAP25 and STX1A. Interacts with rotavirus A NSP4. Interacts (via the N-terminus) with DPP4; the interaction is direct. Interacts with CTNNB1, CDH1 and JUP. Interacts with PACSIN2. Interacts with SLC7A9 (By similarity). Interacts with BMX and BTK.By similarity5 Publications
Binary interactionsi
With | Entry | #Exp. | IntAct | Notes |
---|---|---|---|---|
Axin1 | O70239 | 5 | EBI-603614,EBI-6857773 | From a different organism. |
BID | P55957 | 3 | EBI-603614,EBI-519672 | |
EGFR | P00533 | 5 | EBI-603614,EBI-297353 | |
F2R | P25116 | 3 | EBI-603614,EBI-2803960 | |
FAS | P25445 | 3 | EBI-603614,EBI-494743 | |
Grb7 | Q03160 | 3 | EBI-603614,EBI-7100053 | From a different organism. |
ID1 | P41134 | 6 | EBI-603614,EBI-1215527 | |
LRP6 | O75581 | 3 | EBI-603614,EBI-910915 | |
MCL1 | Q07820 | 3 | EBI-603614,EBI-1003422 | |
NR3C1 | P04150 | 2 | EBI-603614,EBI-493507 | |
PTPN1 | P18031 | 5 | EBI-603614,EBI-968788 | |
SCP2 | P22307 | 3 | EBI-603614,EBI-1050999 | |
TXNRD1 | Q16881 | 4 | EBI-603614,EBI-716617 |
Protein-protein interaction databases
BioGridi | 107305. 120 interactions. |
DIPi | DIP-5960N. |
IntActi | Q03135. 38 interactions. |
MINTi | MINT-152933. |
STRINGi | 9606.ENSP00000339191. |
Structurei
3D structure databases
ProteinModelPortali | Q03135. |
ModBasei | Search... |
MobiDBi | Search... |
Topological domain
Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | Actions |
---|---|---|---|---|---|---|
Topological domaini | 2 – 104 | 103 | CytoplasmicSequence Analysis | Add BLAST | ||
Topological domaini | 126 – 178 | 53 | CytoplasmicSequence Analysis | Add BLAST |
Intramembrane
Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | Actions |
---|---|---|---|---|---|---|
Intramembranei | 105 – 125 | 21 | HelicalSequence Analysis | Add BLAST |
Family & Domainsi
Sequence similaritiesi
Belongs to the caveolin family.Curated
Phylogenomic databases
eggNOGi | NOG86001. |
GeneTreei | ENSGT00390000014924. |
HOVERGENi | HBG003422. |
InParanoidi | Q03135. |
KOi | K06278. |
OMAi | RINMQKE. |
OrthoDBi | EOG7V1FSD. |
PhylomeDBi | Q03135. |
TreeFami | TF315736. |
Family and domain databases
InterProi | IPR001612. Caveolin. IPR015504. Caveolin_1. IPR018361. Caveolin_CS. [Graphical view] |
PANTHERi | PTHR10844. PTHR10844. 1 hit. PTHR10844:SF5. PTHR10844:SF5. 1 hit. |
Pfami | PF01146. Caveolin. 1 hit. [Graphical view] |
PROSITEi | PS01210. CAVEOLIN. 1 hit. [Graphical view] |
Sequences (2)i
Sequence statusi: Complete.
: The displayed sequence is further processed into a mature form. Sequence processingi
This entry describes 2 produced by isoformsialternative initiation. Align
Isoform 1 (identifier: Q03135-1) [UniParc]FASTAAdd to Basket
This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
10 20 30 40 50
MSGGKYVDSE GHLYTVPIRE QGNIYKPNNK AMADELSEKQ VYDAHTKEID
60 70 80 90 100
LVNRDPKHLN DDVVKIDFED VIAEPEGTHS FDGIWKASFT TFTVTKYWFY
110 120 130 140 150
RLLSALFGIP MALIWGIYFA ILSFLHIWAV VPCIKSFLIE IQCISRVYSI
160 170
YVHTVCDPLF EAVGKIFSNV RINLQKEI
Experimental Info
Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | Actions |
---|---|---|---|---|---|---|
Sequence conflicti | 82 – 82 | 1 | D → H in CAA79476. (PubMed:1360410)Curated | |||
Sequence conflicti | 144 – 144 | 1 | I → T in CAA79476. (PubMed:1360410)Curated |
Natural variant
Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | Actions |
---|---|---|---|---|---|---|
Natural varianti | 132 – 132 | 1 | P → L in breast cancer; seems to form misfolded oligomers that are retained within the Golgi complex and are not targeted to caveolae or the plasma membrane. 1 Publication | VAR_015103 |
Alternative sequence
Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | Actions |
---|---|---|---|---|---|---|
Alternative sequencei | 1 – 31 | 31 | Missing in isoform 2. Curated | VSP_018692 | Add BLAST |
Sequence databases
Select the link destinations: EMBL GenBank DDBJ Links Updated | Z18951 mRNA. Translation: CAA79476.1. AF095593, AF095591, AF095592 Genomic DNA. Translation: AAD23745.1. AJ133269 Genomic DNA. Translation: CAB63654.1. AF125348 Genomic DNA. Translation: AAD34722.1. BT007143 mRNA. Translation: AAP35807.1. BC009685 mRNA. Translation: AAH09685.1. BC082246 mRNA. Translation: AAH82246.1. |
CCDSi | CCDS55156.1. [Q03135-2] CCDS5767.1. [Q03135-1] |
PIRi | S26884. |
RefSeqi | NP_001744.2. NM_001753.4. [Q03135-1] |
UniGenei | Hs.74034. |
Genome annotation databases
Ensembli | ENST00000341049; ENSP00000339191; ENSG00000105974. [Q03135-1] ENST00000393467; ENSP00000377110; ENSG00000105974. [Q03135-2] ENST00000393468; ENSP00000377111; ENSG00000105974. [Q03135-2] ENST00000405348; ENSP00000384348; ENSG00000105974. [Q03135-2] ENST00000614113; ENSP00000479447; ENSG00000105974. [Q03135-2] |
GeneIDi | 857. |
KEGGi | hsa:857. |
UCSCi | uc003vif.2. human. [Q03135-1] |
Polymorphism databases
DMDMi | 13637934. |
Keywords - Coding sequence diversityi
Alternative initiationCross-referencesi
Web resourcesi
Atlas of Genetics and Cytogenetics in Oncology and Haematology |
Wikipedia
Caveolin entry |
Sequence databases
Select the link destinations:
EMBL GenBank DDBJ Links Updated
|
Z18951
mRNA. Translation: CAA79476.1
. AF095593 , AF095591 , AF095592 Genomic DNA. Translation: AAD23745.1 . AJ133269 Genomic DNA. Translation: CAB63654.1 . AF125348 Genomic DNA. Translation: AAD34722.1 . BT007143 mRNA. Translation: AAP35807.1 . BC009685 mRNA. Translation: AAH09685.1 . BC082246 mRNA. Translation: AAH82246.1 . |
CCDSi | CCDS55156.1.
[Q03135-2
] CCDS5767.1. [Q03135-1 ] |
PIRi | S26884.
|
RefSeqi | NP_001744.2.
NM_001753.4.
[Q03135-1
] |
UniGenei | Hs.74034. |
3D structure databases
ProteinModelPortali | Q03135.
|
ModBasei | Search...
|
MobiDBi | Search...
|
Protein-protein interaction databases
BioGridi | 107305.
120 interactions. |
DIPi | DIP-5960N.
|
IntActi | Q03135.
38 interactions. |
MINTi | MINT-152933.
|
STRINGi | 9606.ENSP00000339191.
|
Protein family/group databases
TCDBi | 8.A.26.1.1.
the caveolin (caveolin) family. |
PTM databases
PhosphoSitei | Q03135.
|
Polymorphism databases
DMDMi | 13637934.
|
Proteomic databases
MaxQBi | Q03135.
|
PaxDbi | Q03135.
|
PeptideAtlasi | Q03135.
|
PRIDEi | Q03135.
|
Protocols and materials databases
DNASUi | 857.
|
Structural Biology Knowledgebase | Search...
|
Genome annotation databases
Ensembli | ENST00000341049
; ENSP00000339191
; ENSG00000105974
. [Q03135-1
] ENST00000393467 ; ENSP00000377110 ; ENSG00000105974 . [Q03135-2 ] ENST00000393468 ; ENSP00000377111 ; ENSG00000105974 . [Q03135-2 ] ENST00000405348 ; ENSP00000384348 ; ENSG00000105974 . [Q03135-2 ] ENST00000614113 ; ENSP00000479447 ; ENSG00000105974 . [Q03135-2 ] |
GeneIDi | 857.
|
KEGGi | hsa:857.
|
UCSCi | uc003vif.2.
human. [Q03135-1
] |
Organism-specific databases
CTDi | 857.
|
GeneCardsi | GC07P116164.
|
HGNCi | HGNC:1527.
CAV1. |
HPAi | CAB003791.
|
MIMi | 601047.
gene. 606721. phenotype. 612526. phenotype. 615343. phenotype. |
neXtProti | NX_Q03135.
|
Orphaneti | 528.
Berardinelli-Seip congenital lipodystrophy. 220393. Diffuse cutaneous systemic sclerosis. 275777. Heritable pulmonary arterial hypertension. 220402. Limited cutaneous systemic sclerosis. |
PharmGKBi | PA26107.
|
GenAtlasi | Search...
|
Phylogenomic databases
eggNOGi | NOG86001.
|
GeneTreei | ENSGT00390000014924.
|
HOVERGENi | HBG003422.
|
InParanoidi | Q03135.
|
KOi | K06278.
|
OMAi | RINMQKE.
|
OrthoDBi | EOG7V1FSD.
|
PhylomeDBi | Q03135.
|
TreeFami | TF315736.
|
Enzyme and pathway databases
Reactomei | REACT_12477.
eNOS activation. REACT_12541. NOSTRIN mediated eNOS trafficking. REACT_12560. Basigin interactions. REACT_494. Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis. |
SignaLinki | Q03135.
|
Miscellaneous databases
ChiTaRSi | CAV1.
human. |
GeneWikii | Caveolin_1.
|
GenomeRNAii | 857.
|
NextBioi | 3556.
|
PROi | Q03135.
|
SOURCEi | Search...
|
Gene expression databases
Bgeei | Q03135.
|
CleanExi | HS_CAV1.
|
ExpressionAtlasi | Q03135.
baseline and differential. |
Genevestigatori | Q03135.
|
Family and domain databases
InterProi | IPR001612.
Caveolin. IPR015504. Caveolin_1. IPR018361. Caveolin_CS. [Graphical view ] |
PANTHERi | PTHR10844.
PTHR10844. 1 hit. PTHR10844:SF5. PTHR10844:SF5. 1 hit. |
Pfami | PF01146.
Caveolin. 1 hit. [Graphical view ] |
PROSITEi | PS01210.
CAVEOLIN. 1 hit. [Graphical view ] |
ProtoNeti | Search...
|
Publicationsi
- "The sequence of human caveolin reveals identity with VIP21, a component of transport vesicles."
Glenney J.R. Jr.
FEBS Lett. 314:45-48(1992) [PubMed] [Europe PMC] [Abstract]Cited for: NUCLEOTIDE SEQUENCE [MRNA].Tissue: Lung. - "Analysis of the CAVEOLIN-1 gene at human chromosome 7q31.1 in primary tumours and tumour-derived cell lines."
Hurlstone A.F., Reid G., Reeves J.R., Fraser J., Strathdee G., Rahilly M., Parkinson E.K., Black D.M.
Oncogene 18:1881-1890(1999) [PubMed] [Europe PMC] [Abstract]Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. - "Sequence and detailed organization of the human caveolin-1 and -2 genes located near the D7S522 locus (7q31.1). Methylation of a CpG island in the 5' promoter region of the caveolin-1 gene in human breast cancer cell lines."
Engelman J.A., Zhang X.L., Lisanti M.P.
FEBS Lett. 448:221-230(1999) [PubMed] [Europe PMC] [Abstract]Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. - "Cloning of human full-length CDSs in BD Creator(TM) system donor vector."
Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S., Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y., Phelan M., Farmer A.
Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databasesCited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. - "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract]Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].Tissue: Brain and Lung. - "N-terminal processing and modifications of caveolin-1 in caveolae from human adipocytes."
Vainonen J.P., Aboulaich N., Turkina M.V., Stralfors P., Vener A.V.
Biochem. Biophys. Res. Commun. 320:480-486(2004) [PubMed] [Europe PMC] [Abstract]Cited for: PROTEIN SEQUENCE OF 2-66, SUBCELLULAR LOCATION, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT SER-2, PHOSPHORYLATION AT SER-37, CLEAVAGE OF INITIATOR METHIONINE (ISOFORM 2), ACETYLATION AT ALA-2 (ISOFORM 2), PHOSPHORYLATION AT SER-6 (ISOFORM 2).Tissue: Adipose tissue. - "Vectorial proteomics reveal targeting, phosphorylation and specific fragmentation of polymerase I and transcript release factor (PTRF) at the surface of caveolae in human adipocytes."
Aboulaich N., Vainonen J.P., Stralfors P., Vener A.V.
Biochem. J. 383:237-248(2004) [PubMed] [Europe PMC] [Abstract]Cited for: PROTEIN SEQUENCE OF 58-65.Tissue: Adipocyte. - "Phosphorylation of caveolin by src tyrosine kinases. The alpha-isoform of caveolin is selectively phosphorylated by v-Src in vivo."
Li S., Seitz R., Lisanti M.P.
J. Biol. Chem. 271:3863-3868(1996) [PubMed] [Europe PMC] [Abstract]Cited for: PHOSPHORYLATION AT TYR-6; TYR-14 AND TYR-25. - "Functional interaction of caveolin-1 with Bruton's tyrosine kinase and Bmx."
Vargas L., Nore B.F., Berglof A., Heinonen J.E., Mattsson P.T., Smith C.I., Mohamed A.J.
J. Biol. Chem. 277:9351-9357(2002) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH BMX AND BTK. - "Identification and characterization of a novel human plant pathogenesis-related protein that localizes to lipid-enriched microdomains in the Golgi complex."
Eberle H.B., Serrano R.L., Fuellekrug J., Schlosser A., Lehmann W.D., Lottspeich F., Kaloyanova D., Wieland F.T., Helms J.B.
J. Cell Sci. 115:827-838(2002) [PubMed] [Europe PMC] [Abstract]Cited for: INTERACTION WITH GLIPR2.Tissue: Brain. - "c-Abl is required for oxidative stress-induced phosphorylation of caveolin-1 on tyrosine 14."
Sanguinetti A.R., Mastick C.C.
Cell. Signal. 15:289-298(2003) [PubMed] [Europe PMC] [Abstract]Cited for: PHOSPHORYLATION AT TYR-14. - "Translocation of endothelial nitric-oxide synthase involves a ternary complex with caveolin-1 and NOSTRIN."
Schilling K., Opitz N., Wiesenthal A., Oess S., Tikkanen R., Mueller-Esterl W., Icking A.
Mol. Biol. Cell 17:3870-3880(2006) [PubMed] [Europe PMC] [Abstract]Cited for: INTERACTION WITH NOSTRIN. - "The rotavirus enterotoxin NSP4 directly interacts with the caveolar structural protein caveolin-1."
Parr R.D., Storey S.M., Mitchell D.M., McIntosh A.L., Zhou M., Mir K.D., Ball J.M.
J. Virol. 80:2842-2854(2006) [PubMed] [Europe PMC] [Abstract]Cited for: INTERACTION WITH ROTAVIRUS A NSP4. - "Caveolin-1 triggers T-cell activation via CD26 in association with CARMA1."
Ohnuma K., Uchiyama M., Yamochi T., Nishibashi K., Hosono O., Takahashi N., Kina S., Tanaka H., Lin X., Dang N.H., Morimoto C.
J. Biol. Chem. 282:10117-10131(2007) [PubMed] [Europe PMC] [Abstract]Cited for: FUNCTION, INTERACTION WITH DPP4, SUBCELLULAR LOCATION. - "Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy."
Kim C.A., Delepine M., Boutet E., El Mourabit H., Le Lay S., Meier M., Nemani M., Bridel E., Leite C.C., Bertola D.R., Semple R.K., O'Rahilly S., Dugail I., Capeau J., Lathrop M., Magre J.
J. Clin. Endocrinol. Metab. 93:1129-1134(2008) [PubMed] [Europe PMC] [Abstract]Cited for: INVOLVEMENT IN CGL3. - "Heterozygous CAV1 frameshift mutations (MIM 601047) in patients with atypical partial lipodystrophy and hypertriglyceridemia."
Cao H., Alston L., Ruschman J., Hegele R.A.
Lipids Health Dis. 7:3-3(2008) [PubMed] [Europe PMC] [Abstract]Cited for: INVOLVEMENT IN LCCNS. - "A quantitative atlas of mitotic phosphorylation."
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P.
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed] [Europe PMC] [Abstract]Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].Tissue: Cervix carcinoma. - "Large-scale proteomics analysis of the human kinome."
Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G., Mann M., Daub H.
Mol. Cell. Proteomics 8:1751-1764(2009) [PubMed] [Europe PMC] [Abstract]Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. - "Lysine acetylation targets protein complexes and co-regulates major cellular functions."
Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C., Olsen J.V., Mann M.
Science 325:834-840(2009) [PubMed] [Europe PMC] [Abstract]Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2 AND LYS-5, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. - "Quantitative phosphoproteomics reveals widespread full phosphorylation site occupancy during mitosis."
Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L., Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.
Sci. Signal. 3:RA3-RA3(2010) [PubMed] [Europe PMC] [Abstract]Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].Tissue: Cervix carcinoma. - "Initial characterization of the human central proteome."
Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.
BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract]Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. - "System-wide temporal characterization of the proteome and phosphoproteome of human embryonic stem cell differentiation."
Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T., Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.
Sci. Signal. 4:RS3-RS3(2011) [PubMed] [Europe PMC] [Abstract]Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-37, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. - "Whole exome sequencing to identify a novel gene (caveolin-1) associated with human pulmonary arterial hypertension."
Austin E.D., Ma L., LeDuc C., Berman Rosenzweig E., Borczuk A., Phillips J.A. III, Palomero T., Sumazin P., Kim H.R., Talati M.H., West J., Loyd J.E., Chung W.K.
Circ. Cardiovasc. Genet. 5:336-343(2012) [PubMed] [Europe PMC] [Abstract]Cited for: INVOLVEMENT IN PPH3. - "N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB."
Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A., Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E., Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.
Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012) [PubMed] [Europe PMC] [Abstract]Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. - "Caveolin-1 mutations (P132L and null) and the pathogenesis of breast cancer: caveolin-1 (P132L) behaves in a dominant-negative manner and caveolin-1 (-/-) null mice show mammary epithelial cell hyperplasia."
Lee H., Park D.S., Razani B., Russell R.G., Pestell R.G., Lisanti M.P.
Am. J. Pathol. 161:1357-1369(2002) [PubMed] [Europe PMC] [Abstract]Cited for: VARIANT LEU-132.
Entry informationi
Entry namei | CAV1_HUMAN | ||||||||
Accessioni | Q03135Primary (citable) accession number: Q03135 Secondary accession number(s): Q9UGP1, Q9UNG1, Q9UQH6 | ||||||||
Entry historyi |
| ||||||||
Entry statusi | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
Annotation program | Chordata Protein Annotation Program | ||||||||
Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. |
Miscellaneousi
Keywords - Technical termi
Complete proteome, Direct protein sequencing, Reference proteomeDocuments
- Human chromosome 7Human chromosome 7: entries, gene names and cross-references to MIM
- Human entries with polymorphisms or disease mutationsList of human entries with polymorphisms or disease mutations
- Human polymorphisms and disease mutationsIndex of human polymorphisms and disease mutations
- MIM cross-referencesOnline Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot
- SIMILARITY commentsIndex of protein domains and families